This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
In-stent Restenosis
and you are
between 18 and 80
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Study purpose The safety and efficacy of paclitaxel controlled release balloon catheter Vasoguard TM in treatment of in-stent restenosis. Study group Experimental group: paclitaxel controlled release balloon catheter Vasoguard TM Control group: paclitaxel release coronary balloon catheter SeQuent Please

Provided treatments

  • Device: paclitaxel controlled release balloon catheter Vasoguard TM
  • Device: paclitaxel release coronary balloon catheter SeQuent Please

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02891018. The sponsor of the trial is Shandong Branden Med.Device Co.,Ltd and it is looking for 260 volunteers for the current phase.
Official trial title:
A Multicenter, Prospective and Randomized Controlled Clinical Study (VasoguardTM Trial II) That Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter (SeQuent Please)